No Data
Breaking Down Klaviyo: 7 Analysts Share Their Views
Zacks.com Featured Highlights Include Wolverine World Wide, BioMarin Pharmaceutical, Datadog, Progressive and Klaviyo
Needham Maintains Klaviyo(KVYO.US) With Buy Rating, Maintains Target Price $40
Express News | Needham Reiterates Buy on Klaviyo, Maintains $40 Price Target
Klaviyo Analyst Ratings
Optimistic Outlook for Klaviyo, Inc.: A Comprehensive Analysis of Market Position and Strategic Partnerships